Ronaldo Puts Money into Healthcare Company Co-Founded by Russian
Football star Ronaldo made a significant investment in Bioniq, a Russian-owned nutritional supplements brand, which has since appreciated in value to approximately $82 million. Read Full Article at RT.com.
TroibNews 
Bioniq, a brand specializing in nutritional supplements, has seen its valuation rise to approximately $82 million following the investment from football star Cristiano Ronaldo.
The Portuguese athlete has taken on the role of shareholder in Bioniq, a healthcare company focused on personalized nutritional supplements. Although the specifics of his investment remain confidential, Bioniq stated that the amount is “significant.” The company noted that following Ronaldo’s participation, its estimated worth has increased to $82 million.
Founded by Vadim Fedotov, a former basketball player from Leningrad and captain of Germany's national team, Bioniq has garnered attention in the health-tech space. Fedotov also held a director position at RuTube, a Russian alternative to YouTube, and was involved with Gazprom Media Holdings in his early career.
Since 2022, Ronaldo has served as an ambassador for the London-based company and has been using Bioniq products for three years. On the company's website, he expressed: “With their personalized health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer.”
Upon becoming a shareholder, the 39-year-old football icon stated that he would also engage in the development of the company’s brand and products. He remarked, “Backing Bioniq goes beyond just an investment opportunity for me–it’s about aligning with a shared vision for health, performance, and longevity.”
Fedotov has lauded Ronaldo’s investment, perceiving him as an ideal partner and shareholder: “As the ultimate embodiment of performance and longevity, Cristiano fully aligns with the values and mission of Bioniq,” the CEO noted.
Bioniq was launched in 2019 by Fedotov and neurosurgeon Konstantin Karuzin, specializing in tailored nutritional supplements and vitamin complexes derived from blood analysis. The company’s products are now available in over 70 countries worldwide; however, Karuzin is no longer associated with the firm.
Camille Lefevre for TROIB News
The Portuguese athlete has taken on the role of shareholder in Bioniq, a healthcare company focused on personalized nutritional supplements. Although the specifics of his investment remain confidential, Bioniq stated that the amount is “significant.” The company noted that following Ronaldo’s participation, its estimated worth has increased to $82 million.
Founded by Vadim Fedotov, a former basketball player from Leningrad and captain of Germany's national team, Bioniq has garnered attention in the health-tech space. Fedotov also held a director position at RuTube, a Russian alternative to YouTube, and was involved with Gazprom Media Holdings in his early career.
Since 2022, Ronaldo has served as an ambassador for the London-based company and has been using Bioniq products for three years. On the company's website, he expressed: “With their personalized health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer.”
Upon becoming a shareholder, the 39-year-old football icon stated that he would also engage in the development of the company’s brand and products. He remarked, “Backing Bioniq goes beyond just an investment opportunity for me–it’s about aligning with a shared vision for health, performance, and longevity.”
Fedotov has lauded Ronaldo’s investment, perceiving him as an ideal partner and shareholder: “As the ultimate embodiment of performance and longevity, Cristiano fully aligns with the values and mission of Bioniq,” the CEO noted.
Bioniq was launched in 2019 by Fedotov and neurosurgeon Konstantin Karuzin, specializing in tailored nutritional supplements and vitamin complexes derived from blood analysis. The company’s products are now available in over 70 countries worldwide; however, Karuzin is no longer associated with the firm.
Camille Lefevre for TROIB News
